Neodopasol combination tablets (YJ code: 1169100F1060, standard: 1 tablet) are manufactured by Alfresa Pharma. This medication combines levodopa, which converts to dopamine in the brain, with benserazide hydrochloride, a peripheral decarboxylase inhibitor, to treat Parkinson’s disease and Parkinsonian syndrome.
Neodopasol combination tablets
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
